يعرض 1 - 20 نتائج من 73 نتيجة بحث عن '"Gordon, Mark F."', وقت الاستعلام: 0.56s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
    Academic Journal
  6. 6
    Academic Journal

    المصدر: Perera , G , Pedersen , L , Ansel , D , Alexander , M , Arrighi , H M , Avillach , P , Foskett , N , Gini , R , Gordon , M F , Gungabissoon , U , Mayer , M A , Novak , G , Rijnbeek , P , Trifirò , G , van der Lei , J , Visser , P J & Stewart , R 2018 , ' Dementia prevalence and incidence in a federation of European Electronic Health Record databases : The European Medical Informatics Framework resource ' , Alzheimer's ....

  7. 7
    Academic Journal
  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
    Academic Journal

    المصدر: Tang , E Y H , Harrison , S L , Errington , L , Gordon , M F , Visser , P J , Novak , G , Dufouil , C , Brayne , C , Robinson , L , Launer , L J & Stephan , B C M 2015 , ' Current Developments in Dementia Risk Prediction Modelling: An Updated Systematic Review ' , PLOS ONE , vol. 10 , no. 9 , e0136181 . https://doi.org/10.1371/journal.pone.0136181

  11. 11
    Academic Journal
  12. 12
  13. 13
    Academic Journal
  14. 14
  15. 15
    Academic Journal

    مصطلحات موضوعية: Psychiatry, Health Sciences

    وصف الملف: application/pdf

    Relation: Berger, Joseph R.; Choi, Dennis; Kaminski, Henry J.; Gordon, Mark F.; Hurko, Orest; D'Cruz, O'Neill; Pleasure, Samuel J.; Feldman, Eva L. (2013). "Importance and hurdles to drug discovery for neurological disease." Annals of Neurology 74(3): 441-446.; https://hdl.handle.net/2027.42/110873; Annals of Neurology; Capehart B, Bass D. Review: managing posttraumatic stress disorder in combat veterans with comorbid traumatic brain injury. J Rehabil Res Dev 2012; 49: 789 – 812.; Victor M, Ropper AH. Degenerative diseases of the nervous system. In: Victor M, Ropper AH, eds. Principles of neurology. 7th ed. New York, NY: McGraw‐Hill, 2001: 1106 – 1174.; Hebert LE, Weuve J, Scherr PA, Evans DA. Alzheimer disease in the United States (2010–2050) estimated using the 2010 census. Neurology 2013; 80: 1778 – 1783.; Caffrey C, Sengupta M, Park‐Lee E, Harris‐Kojetin L. National Survey of Residential Care Facilities. Available at: http://www.cdc.gov/nchs/nsrcf/nsrcf_questionnaires.htm. Accessed June 11, 2013.; Brown RD, Whisnant JP, Sicks JD, et al. Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke 1996; 27: 373 – 380.; Muntner P, Garrett E, Klag MJ, Coresh J. Trends in stroke prevalence between 1973 and 1991 in the US population 25 to 74 years of age. Stroke 2002; 33: 1209 – 1213.; Gordon NF, Gulanick M, Costa F, et al. Physical activity and exercise recommendations for stroke survivors: an American Heart Association scientific statement from the Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention; the Council on Cardiovascular Nursing; the Council on Nutrition, Physical Activity, and Metabolism; and the Stroke Council. Circulation 2004; 109: 2031 – 2041.; Murphy SM, Puwanant A, Griggs RC. Unintended effects of orphan product designation for rare neurological diseases. Ann Neurol 2012; 72: 481 – 490.; Alexander JC, Salazar DE. Modern drug discovery and development. In: Robertson D, ed. Clinical and translational science: principles of human research. London, UK: Academic Press, 2009: 361 – 380.; Ledford H. Translational research: 4 ways to fix the clinical trial. Nature 2011; 477: 526 – 528.; US Food and Drug Administration. Summary of NDA approvals & receipts, 1938 to the present. 2013. Available at: http://www.fda.gov/AboutFDA/WhatWeDo/History/ProductRegulation/SummaryofNDAApprovalsReceipts1938tothepresent/default.htm Accessed June 6, 2013.; Miller G. Is pharma running out of brainy ideas? Science 2010; 329: 502 – 504.; Paul SM, Mytelka DS, Dunwiddie CT, et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nat Rev Drug Discov 2010; 9: 203 – 214.; Dorsey ER, Thompson JP, Carrasco M, et al. Financing of U.S. biomedical research and new drug approvals across therapeutic areas. PLoS One 2009; 4: e7015.; Dorsey ER, Vitticore P, De Roulet J, et al. Financial anatomy of neuroscience research. Ann Neurol 2006; 60: 652 – 659.; Pammolli F, Magazzini L, Riccaboni M. The productivity crisis in pharmaceutical R&D. Nat Rev Drug Discov 2011; 10: 428 – 438.; Kaitin KI, DiMasi JA. Pharmaceutical innovation in the 21st century: new drug approvals in the first decade 2000–2009. Clin Pharmacol Ther 2011; 89: 183 – 188.; Kelland K. Analysis: Neuroscience under threat as Big Pharma backs off. Reuters; 2011. Available at: http://www.reuters.com/article/2011/02/11/us‐neuroscience‐pharma‐idUSTRE71A2E120110211 Accessed June 8, 2013.; The brain drain. Pharmafile; 2012. Available at: http://www.pharmafile.com/news/172099/brain‐drain Accessed June 8, 2013.; Hurko O. The uses of biomarkers in drug development. Ann NY Acad Sci 2009; 1180: 1 – 10.; Leppert D, Glanzman R. On being a neurologist in industry. Ann Neurol 2013; 73: 319 – 326.; Duchan E, Patel DR. Epidemiology of autism spectrum disorders. Pediatr Clin North Am 2012; 59: 27 – 43, ix–x.; CDC. Prevalence of autism spectrum disorders—autism and developmental disabilities monitoring network, 14 sites, United States, 2008. MMWR Surveill Summ 2012; 61: 1 – 19.; Hirtz D, Thurman DJ, Gwinn‐Hardy K, et al. How common are the “common” neurologic disorders? Neurology 2007; 68: 326 – 337.; Martin JA. Preterm births—United States, 2007. MMWR Surveill Summ 2011; 60 ( suppl ): 78 – 79.; Jankovic J, Kurlan R. Tourette syndrome: evolving concepts. Mov Disord 2011; 26: 1149 – 1156.; Lipton RB, Scher AI, Kolodner K, et al. Migraine in the United States: epidemiology and patterns of health care use. Neurology 2002; 58: 885 – 894.; Lipton RB, Stewart WF, Scher AI. Epidemiology and economic impact of migraine. Curr Med Res Opin 2001; 17 ( suppl 1 ): s4 – s12.; Hauser WA, Annegers JF. Epidemiology of epilepsy. In: Laidlaw JP, Richens A, Chadwick D, eds. Textbook of epilepsy. New York, NY: Churchill‐Livingstone, 1992: 23 – 45.; Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935–1984. Epilepsia 1993; 34: 453 – 468.; Hauser WA, Annegers JF, Rocca WA. Descriptive epidemiology of epilepsy: contributions of population‐based studies from Rochester, Minnesota. Mayo Clin Proc 1996; 71: 576 – 586.; Taylor BC, Hagel EM, Carlson KF, et al. Prevalence and costs of co‐occurring traumatic brain injury with and without psychiatric disturbance and pain among Afghanistan and Iraq War Veteran V.A. users. Med Care 2012; 50: 342 – 346.; Saulle M, Greenwald BD. Chronic traumatic encephalopathy: a review. Rehabil Res Pract 2012;2012: 816069.; Stern RA, Riley DO, Daneshvar DH, et al. Long‐term consequences of repetitive brain trauma: chronic traumatic encephalopathy. PM R 2011; 3 ( 10 suppl 2 ): S460 – S467.; Noonan CW, Williamson DM, Henry JP, et al. The prevalence of multiple sclerosis in 3 US communities. Prev Chronic Dis 2009; 7: A12.; Guyer B, Freedman MA, Strobino DM, Sondik EJ. Annual summary of vital statistics: trends in the health of Americans during the 20th century. Pediatrics 2000; 106: 1307 – 1317.; Centers for Disease Control and Prevention. Health, United States, 2011. 2012. Available at: http://www.cdc.gov/nchs/data/hus/hus11.pdf#fig33. Accessed June 6, 2013.; Administration on Aging. Projected future growth of the older population 2012. Available at: http://www.aoa.gov/AoARoot/Aging_Statistics/future_growth/future_growth.aspx Accessed January 29, 2013.; Wang HS. Dementia in old age. In: Smith LW, Kinsbourne M, eds. Aging and dementia. New York, NY: Spectrum, 1977: 1 – 4.; Schoenberg BS, Kokmen E, Okazaki H. Alzheimer's disease and other dementing illnesses in a defined United States population: incidence rates and clinical features. Ann Neurol 1987; 22: 724 – 729.

  16. 16
    Academic Journal
  17. 17
    Academic Journal
  18. 18
    Academic Journal

    المساهمون: Brain Endowment Bank which was sponsored by NPF, OAR awarded NPF fellowhip, Morris K. Udall Parkinson's Disease Research Center of Excellence National Institute of Neurological Disorders and Stroke, State of Florida Alzheimer Disease Initiative, Society for Progressive Supranuclear Palsy, NIH, National Institute on Aging, National Institute of Environmental Health Sciences

    المصدر: Annals of Neurology ; volume 59, issue 2, page 388-393 ; ISSN 0364-5134 1531-8249

  19. 19
    Academic Journal
  20. 20
    Academic Journal